BBVA USA Bancshares’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,473	Closed	-$270K	–	503
2019 Q2	$270K	Sell	1,473 -639	-30%	-$112K	0.02%	468
2019 Q1	$388K	Sell	2,112 -535	-20%	-$98.8K	0.02%	398
2018 Q4	$439K	Sell	2,647 -295	-10%	-$51.1K	0.03%	355
2018 Q3	$567K	Buy	2,942 +483	+20%	+$86K	0.03%	367
2018 Q2	$418K	Sell	2,459 -83	-3%	-$12.9K	0.03%	396
2018 Q1	$414K	Sell	2,542 -171	-6%	-$27.9K	0.03%	399
2017 Q4	$407K	Sell	2,713 -517	-16%	-$76.6K	0.03%	400
2017 Q3	$491K	Sell	3,230 -633	-16%	-$95.3K	0.03%	367
2017 Q2	$498K	Buy	3,863 +385	+11%	+$46.3K	0.03%	363
2017 Q1	$380K	Sell	3,478 -726	-17%	-$63.9K	0.03%	408
2016 Q4	$310K	Sell	4,204 -430	-9%	-$35K	0.02%	452
2016 Q3	$404K	Sell	4,634 -344	-7%	-$32.5K	0.03%	393
2016 Q2	$428K	Sell	4,978 -613	-11%	-$53K	0.03%	365
2016 Q1	$444K	Buy	5,591 +341	+6%	+$30.8K	0.03%	369
2015 Q4	$660K	Buy	5,250 +866	+20%	+$105K	0.05%	300
2015 Q3	$457K	Buy	4,384 +977	+29%	+$126K	0.04%	332
2015 Q2	$420K	Buy	3,407 +622	+22%	+$78.4K	0.02%	381
2015 Q1	$328K	Buy	2,785 +1,060	+61%	+$127K	0.01%	463
2014 Q4	$205K	Buy	+1,725	New	+$194K	0.01%	531